論文 - 成田 拓磨
-
TMEM2 is a bona fide hyaluronidase possessing intrinsic catalytic activity.
Narita T, Tobisawa Y, Bobkov A, Jackson M, Ohyama C, Irie F, Yamaguchi Y
The Journal of biological chemistry 299 ( 9 ) 105120 2023年09月
-
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.
Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Translational andrology and urology 12 ( 2 ) 161 - 167 2023年02月
-
Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.
Fujita N, Hatakeyama S, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 29 ( 8 ) 867 - 875 2022年08月
-
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.
Togashi K, Hatakeyama S, Yoneyama T, Hamaya T, Narita T, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 29 ( 7 ) 733 - 739 2022年07月
-
Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.
Iwamura H, Mizuno K, Akamatsu S, Hatakeyama S, Tobisawa Y, Narita S, Narita T, Yamashita S, Kawamura S, Sakurai T, Fujita N, Kodama H, Noro D, Kakizaki I, Nakaji S, Itoh K, Tsuchiya N, Ito A, Habuchi T, Ohyama C, Yoneyama T
Cancer science 113 ( 7 ) 2434 - 2445 2022年07月
-
Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy.
Iwamura H, Hatakeyama S, Narita T, Ozaki Y, Konishi S, Horiguchi H, Kodama H, Kojima Y, Fujita N, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Scientific reports 12 ( 1 ) 9675 2022年06月
-
Management of bladder cancer in older patients.
Hatakeyama S, Narita S, Okita K, Narita T, Iwamura H, Fujita N, Inokuchi J, Matsui Y, Kitamura H, Ohyama C
Japanese journal of clinical oncology 52 ( 3 ) 203 - 213 2022年03月
-
Editorial Comment to Comparative oncological outcomes after radical prostatectomy or external beam radiation therapy plus androgen deprivation therapy in men with clinical T3b prostate cancer.
Narita T, Hatakeyama S, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 2022年03月
-
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.
Okuyama Y, Hatakeyama S, Numakura K, Narita T, Tanaka T, Miura Y, Sasaki D, Noro D, Tokui N, Okamoto T, Yamamoto H, Narita S, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C
BJUI compass 3 ( 2 ) 154 - 161 2022年03月
-
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.
Yoneyama T, Yamamoto H, Sutoh Yoneyama M, Tobisawa Y, Hatakeyama S, Narita T, Kodama H, Momota M, Ito H, Narita S, Tsushima F, Mitsuzuka K, Yoneyama T, Hashimoto Y, Duivenvoorden W, Pinthus JH, Kakeda S, Ito A, Tsuchiya N, Habuchi T, Ohyama C
The Prostate 81 ( 16 ) 1411 - 1427 2021年12月
-
Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries.
Konishi S, Narita T, Hatakeyama S, Yoneyama T, Yoneyama MS, Tobisawa Y, Noro D, Sato T, Togashi K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Scientific reports 11 ( 1 ) 22103 2021年11月
-
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.
Narita T, Hatakeyama S, Numakura K, Kobayashi M, Muto Y, Saito M, Narita S, Tanaka T, Noro D, Tokui N, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 28 ( 9 ) 899 - 905 2021年09月
-
The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).
Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 39 ( 3 ) 192.e7 - 192.e14 2021年03月
-
Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.
Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Urologic oncology 39 ( 3 ) 191.e9 - 191.e16 2021年03月
-
A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.
Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologia internationalis 105 ( 3-4 ) 232 - 239 2021年03月
-
Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.
Fujita N, Hatakeyama S, Okita K, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
Urologic oncology 39 ( 3 ) 191.e9 - 191.e16 2021年03月
-
The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).
Togashi K, Hatakeyama S, Kojima Y, Momota M, Narita T, Iwamura H, Hamano I, Hamaya T, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Urologic oncology 39 ( 3 ) 192.e7 - 192.e14 2021年03月
-
Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).
Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Translational andrology and urology 10 ( 3 ) 1143 - 1151 2021年03月
-
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).
Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of clinical oncology 26 ( 1 ) 199 - 206 2021年01月
-
Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis.
Takuma Narita, Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Jiro Shimoda, Toshiaki Kawaguchi, Shigeto Ishidoya, Koji Mitsuzuka, Yoichi Arai, Akihiro Ito, Norihiko Tsuchiya, Tomonori Habuchi, Chikara Ohyama
Translational andrology and urology 10 ( 1 ) 417 - 425 2021年01月